[go: up one dir, main page]

AU2001277172A1 - Bstp-trans protein and related reagents and methods of use thereof - Google Patents

Bstp-trans protein and related reagents and methods of use thereof

Info

Publication number
AU2001277172A1
AU2001277172A1 AU2001277172A AU7717201A AU2001277172A1 AU 2001277172 A1 AU2001277172 A1 AU 2001277172A1 AU 2001277172 A AU2001277172 A AU 2001277172A AU 7717201 A AU7717201 A AU 7717201A AU 2001277172 A1 AU2001277172 A1 AU 2001277172A1
Authority
AU
Australia
Prior art keywords
bstp
methods
related reagents
trans protein
trans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277172A
Inventor
David Botstein
Patrick O Brown
Chuck Perou
Brian Ring
Douglas Ross
Rob Seitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Genomics Inc
Leland Stanford Junior University
Original Assignee
Applied Genomics Inc
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Genomics Inc, Leland Stanford Junior University filed Critical Applied Genomics Inc
Publication of AU2001277172A1 publication Critical patent/AU2001277172A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001277172A 2000-07-26 2001-07-26 Bstp-trans protein and related reagents and methods of use thereof Abandoned AU2001277172A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22096700P 2000-07-26 2000-07-26
US60/220,967 2000-07-26
PCT/US2001/023440 WO2002008261A2 (en) 2000-07-26 2001-07-26 Bstp-trans protein and related reagents and methods of use thereof

Publications (1)

Publication Number Publication Date
AU2001277172A1 true AU2001277172A1 (en) 2002-02-05

Family

ID=22825782

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2001278070A Abandoned AU2001278070A1 (en) 2000-07-26 2001-07-26 Basal cell markers in breast cancer and uses thereof
AU2001277172A Abandoned AU2001277172A1 (en) 2000-07-26 2001-07-26 Bstp-trans protein and related reagents and methods of use thereof
AU2001278076A Abandoned AU2001278076A1 (en) 2000-07-26 2001-07-26 Bstp-5 proteins and related reagents and methods of use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001278070A Abandoned AU2001278070A1 (en) 2000-07-26 2001-07-26 Basal cell markers in breast cancer and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001278076A Abandoned AU2001278076A1 (en) 2000-07-26 2001-07-26 Bstp-5 proteins and related reagents and methods of use thereof

Country Status (3)

Country Link
US (2) US7118853B2 (en)
AU (3) AU2001278070A1 (en)
WO (3) WO2002008262A2 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) * 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
WO2002055701A2 (en) * 2000-12-15 2002-07-18 Millennium Pharm Inc Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
CA2438206A1 (en) * 2001-02-09 2002-10-03 Incyte Genomics, Inc. Transporters and ion channels
WO2002100892A1 (en) * 2001-05-29 2002-12-19 Regents Of The University Of Michigan Systems and methods for the analysis of proteins
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
DK1410011T3 (en) 2001-06-18 2011-07-18 Netherlands Cancer Inst Diagnosis and prognosis of breast cancer patients
EP2261368A1 (en) 2002-03-13 2010-12-15 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
NZ535925A (en) * 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
US20050027729A1 (en) * 2002-05-22 2005-02-03 Allan Kuchinsky System and methods for visualizing and manipulating multiple data values with graphical views of biological relationships
US20040027350A1 (en) * 2002-08-08 2004-02-12 Robert Kincaid Methods and system for simultaneous visualization and manipulation of multiple data types
US8131471B2 (en) * 2002-08-08 2012-03-06 Agilent Technologies, Inc. Methods and system for simultaneous visualization and manipulation of multiple data types
US20050216459A1 (en) * 2002-08-08 2005-09-29 Aditya Vailaya Methods and systems, for ontological integration of disparate biological data
AT412678B (en) * 2002-09-30 2005-05-25 Gerhard Dr Kranner METHOD FOR COMPUTER-ASSISTED PREPARATION OF PROGNOSES FOR OPERATIONAL SYSTEMS AND SYSTEM FOR CREATING PROGNOSES FOR OPERATIONAL SYSTEMS
WO2004110345A2 (en) * 2002-10-29 2004-12-23 Pharmacia Corporation Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
CA2506066A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
CA2516553C (en) 2003-02-20 2013-04-16 Genomic Health, Inc. Use of intronic rna to measure gene expression
US8168568B1 (en) 2003-03-10 2012-05-01 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Combinatorial therapy for protein signaling diseases
US7825929B2 (en) * 2003-04-04 2010-11-02 Agilent Technologies, Inc. Systems, tools and methods for focus and context viewing of large collections of graphs
WO2005039382A2 (en) 2003-06-24 2005-05-06 Genomic Health Prediction of likelihood of cancer recurrence
EP1644858B1 (en) 2003-07-10 2017-12-06 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP4718490B2 (en) 2003-12-23 2011-07-06 ジェノミック ヘルス， インコーポレイテッド General amplification of fragmented RNA
EP1730308A4 (en) 2004-03-05 2008-10-08 Rosetta Inpharmatics Llc Classification of breast cancer patients using a combination of clinical criteria and informative genesets
CA2848463A1 (en) 2004-04-09 2005-10-27 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
US20050260659A1 (en) * 2004-04-23 2005-11-24 Exagen Diagnostics, Inc. Compositions and methods for breast cancer prognosis
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
US7587279B2 (en) 2004-07-06 2009-09-08 Genomic Health Method for quantitative PCR data analysis system (QDAS)
US20060041387A1 (en) * 2004-08-17 2006-02-23 Xiumei Sun Smart microarray cancer detection system
JP5184087B2 (en) * 2004-09-22 2013-04-17 トリパス イメージング， インコーポレイテッド Methods and computer program products for analyzing and optimizing marker candidates for cancer prognosis
JP4939425B2 (en) 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド Molecular indicators of prognosis and prediction of treatment response in breast cancer
CA3061785A1 (en) 2004-11-05 2006-05-18 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
CN100354304C (en) * 2005-01-18 2007-12-12 北京大学 Breast cancer related gene DREE, its coded protein and uses
CN100354303C (en) * 2005-01-18 2007-12-12 北京大学 GIBC gene and its coded protein and uses
NZ562234A (en) 2005-04-26 2009-09-25 Pfizer P-cadherin antibodies
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
PL1760088T3 (en) * 2005-09-05 2008-10-31 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
CA2624086A1 (en) * 2005-09-28 2007-04-05 H. Lee Moffitt Cancer Center Individualized cancer treatments
US7723477B2 (en) * 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
AU2006308847C1 (en) * 2005-10-31 2012-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
PT2500360E (en) 2005-10-31 2015-10-15 Oncomed Pharm Inc Compositions and methods for diagnosing and treating cancer
WO2007075672A2 (en) * 2005-12-23 2007-07-05 Lankenau Institute For Medical Research Prognostic cancer markers
WO2008121102A2 (en) * 2006-02-21 2008-10-09 The Regents Of The University Of Michigan Hedgehog signaling pathway antagonist cancer treatment
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
BRPI0711011A2 (en) 2006-05-18 2011-08-23 Molecular Profiling Inst Inc method for determining medical intervention for a disease state, method for identifying drug therapy capable of interacting with a molecular target, and system for determining individualized medical intervention for a disease state
CA2653398A1 (en) * 2006-05-26 2007-12-06 Board Of Regents, The University Of Texas System Reverse phase protein array, protein activation and expression signatures, and associated methods
US7533070B2 (en) * 2006-05-30 2009-05-12 Honeywell International Inc. Automatic fault classification for model-based process monitoring
US20080221395A1 (en) * 2006-12-28 2008-09-11 Potts Steven J Self-organizing maps in clinical diagnostics
US20080161652A1 (en) * 2006-12-28 2008-07-03 Potts Steven J Self-organizing maps in clinical diagnostics
EP2106439B1 (en) 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
AU2012261725B2 (en) * 2007-02-21 2014-11-27 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing tumor-associated antigens
AU2013201340B2 (en) * 2007-02-21 2014-11-27 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing tumor-associated antigens
TWI494319B (en) 2007-02-21 2015-08-01 Oncotherapy Science Inc Peptide vaccine for cancers exhibiting tumor-associated antigens
US20100292303A1 (en) * 2007-07-20 2010-11-18 Birrer Michael J Gene expression profile for predicting ovarian cancer patient survival
CA2696591C (en) * 2007-08-20 2016-10-11 Oncotherapy Science, Inc. Cdh3 peptide and medicinal agent comprising the same
US20110166028A1 (en) * 2007-08-28 2011-07-07 Donald Bergstrom Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
MX2011003183A (en) 2008-09-26 2011-04-21 Oncomed Pharm Inc Frizzled-binding agents and uses thereof.
US20100261224A1 (en) 2009-04-10 2010-10-14 Felsher Dean W Discovery and validation of cancer biomarkers using a protein analysis methodology to analyze specimens
US20110103655A1 (en) * 2009-11-03 2011-05-05 Young Warren G Fundus information processing apparatus and fundus information processing method
TWI535445B (en) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt antagonists and methods of treatment and screening
KR20130043102A (en) 2010-04-01 2013-04-29 온코메드 파마슈티칼스, 인크. Frizzled-binding agents and uses thereof
US9042970B2 (en) 2010-06-15 2015-05-26 Ying-Chiang Lu Method and system for facilitating remote medical diagnosis and consultation
WO2013022688A1 (en) * 2011-08-05 2013-02-14 Siemens Healthcare Diagnostics Inc. Automated detection of diagnostically relevant regions in pathology images
JP2014071592A (en) * 2012-09-28 2014-04-21 Fujifilm Corp System, control method and control program for dosage effect prediction
HK1212216A1 (en) 2012-10-23 2016-06-10 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
HK1211887A1 (en) 2013-02-04 2016-06-03 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
TWI658049B (en) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 KNTC2 peptide and vaccine containing the peptide
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
PE20170912A1 (en) 2014-11-14 2017-07-12 Novartis Ag ANTIBODY-DRUG CONJUGATES
CN108456730B (en) * 2018-02-27 2021-01-05 海门善准生物科技有限公司 Application of recurrence risk gene group as marker in preparation of product for evaluating recurrence risk at distant place in breast cancer molecular typing
CN108441559B (en) * 2018-02-27 2021-01-05 海门善准生物科技有限公司 Application of immune-related gene group as marker in preparation of product for evaluating distant metastasis risk of high-proliferative breast cancer
CN112034175A (en) * 2020-04-03 2020-12-04 苏州艾可瑞斯生物科技有限公司 ApoA-II and ApoC-II detection mixed quality control product and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158893A (en) * 1986-12-11 1992-10-27 Peralta Cancer Research Institute Methods and compositions for screening carcinomas
WO1998021242A1 (en) * 1996-11-15 1998-05-22 Human Genome Sciences, Inc. Calcitonin receptor
WO1998022139A1 (en) 1996-11-22 1998-05-28 La Jolla Institute For Allergy And Immunology Detection of galectin-4 in human tumors
AUPO957397A0 (en) * 1997-10-01 1997-10-30 St. Vincent's Institute Of Medical Research Transporter protein
JP2002502977A (en) * 1998-02-04 2002-01-29 インビトロジェン コーポレイション Microarrays and their uses
PT1068528E (en) * 1998-02-25 2006-12-29 Us Gov Health & Human Serv Method and apparatus for making an array for rapid molecular profiling
AU2001263233A1 (en) * 2000-05-19 2001-12-03 Millennium Pharmaceuticals, Inc. 57805, a novel human cadherin family member and uses thereof
CA2410084A1 (en) * 2000-05-26 2001-12-06 Incyte Genomics, Inc. Transporters and ion channels

Also Published As

Publication number Publication date
US20030086934A1 (en) 2003-05-08
WO2002008261A3 (en) 2002-08-15
WO2002008765A2 (en) 2002-01-31
US7118853B2 (en) 2006-10-10
AU2001278070A1 (en) 2002-02-05
WO2002008262A2 (en) 2002-01-31
WO2002008262A3 (en) 2003-01-23
AU2001278076A1 (en) 2002-02-05
WO2002008765A3 (en) 2003-11-20
WO2002008261A2 (en) 2002-01-31
US20060040302A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
AU2001296466A1 (en) Kini-3 motor protein and methods for its use
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001274566A1 (en) Novel protein and dna thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2001292468A1 (en) Methods and means of rna analysis
AU2001284651A1 (en) Secreted proteins and methods of using same
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU5634400A (en) Shank proteins and methods of use thereof
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2001277200A1 (en) Bstp-cad protein and related reagents and methods of use thereof
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2001297707A1 (en) Motor proteins and methods for their use
AU2002239235A1 (en) Gpcr-like protein and nucleic acids encoding same
AU2002248697A1 (en) Novel rgs9 protein binding interactions and methods of use thereof
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor
AU2002240921A1 (en) Medane genes and proteins